Suppr超能文献

[金黄色葡萄球菌和革兰氏阴性菌对氨基糖苷类和头孢菌素类的耐药模式]

[Patterns of resistance of Staph aureus and gram-negative bacteria to aminoglycosides and cephalosporins].

作者信息

Ruczkowska J, Dolna I

出版信息

Wiad Lek. 1989 May 1;42(9):579-83.

PMID:2629327
Abstract

The sensitivity to 4 aminoglycoside antibiotics (gentamicin, tobramycin, netilmycin and amicacin) and 5 cephalosporins (cefradine, cefamandol, cefotaxime, cefoperazone and ceftriaxone) was determined in 700 bacterial strains isolated from clinical materials in the years 1986-1987. The most frequent coexistent resistance was observed to gentamicin and tobramycin in S. aureus (30%), Klebsiella (30%), Proteus mirabilis (28%) and Enterobacter (23%). Resistance to 5 cephalosporins was found in Enterobacter (28%), Proteus spp (18%), Klebsiella (10%). Resistance to cefradine only was found in 13% of E. coli and 27% of Proteus mirabilis strains, and resistance to cefradine and cefamandol in 30% of Proteus ssp strains S. aureus strains were resistant to cefradine, cefotaxime, cefoperazone and ceftriaxone in 28% of cases. Multiple resistance was found in the strains of Enterobacter, Proteus, Pseudomonas and S. aureus which were isolated mainly in intense therapy, surgery and haematology departments. Among aminoglycosides netilmycin and amicacin were most active, among cefalosporins ceftriaxone was most effective against Gram-negative bacteria, and cefamandol against S. aureus.

摘要

对1986 - 1987年从临床材料中分离出的700株细菌菌株测定了其对4种氨基糖苷类抗生素(庆大霉素、妥布霉素、奈替米星和阿米卡星)和5种头孢菌素(头孢拉定、头孢孟多、头孢噻肟、头孢哌酮和头孢曲松)的敏感性。在金黄色葡萄球菌、克雷伯菌、奇异变形杆菌和肠杆菌中,最常见的共存耐药情况是对庆大霉素和妥布霉素耐药(分别为30%、30%、28%和23%)。在肠杆菌(28%)、变形杆菌属(18%)、克雷伯菌(10%)中发现了对5种头孢菌素的耐药性。仅在13%的大肠杆菌和27%的奇异变形杆菌菌株中发现对头孢拉定耐药,在30%的变形杆菌属菌株中发现对头孢拉定和头孢孟多耐药。28%的金黄色葡萄球菌菌株对头孢拉定、头孢噻肟、头孢哌酮和头孢曲松耐药。在主要从强化治疗科、外科和血液科分离出的肠杆菌、变形杆菌、假单胞菌和金黄色葡萄球菌菌株中发现了多重耐药性。在氨基糖苷类抗生素中,奈替米星和阿米卡星活性最强;在头孢菌素中,头孢曲松对革兰氏阴性菌最有效,头孢孟多对金黄色葡萄球菌最有效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验